Episode Details

Back to Episodes

E115: Benralizumab for EGPA - the MANDARA Study

Episode 116 Published 1 year, 6 months ago

Description

Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.

MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.